Arca
Skip to content
Tools
Tools

D2-like dopamine receptor

Family in Homo sapiens that 15 drugs act on.

  • Drugs that act on it: 15
  • Approved: 15
  • In phases 1 to 3: 0
  • Sponsors: 12
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on DRD2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 15

Approved15

  • Olanzapine
  • Pramipexole
  • Haloperidol
  • Haloperidol decanoate
  • Apomorphine
  • Bromocriptine
  • Droperidol
  • Rotigotine
  • Chlorpromazine
  • Ropinirole
  • Trifluoperazine
  • Levomepromazine
  • Loxapine
  • Promazine
  • Thioridazine

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 8 of 15 act as: D2-like dopamine receptor antagonist; the rest name their own mechanism.
        OlanzapineBoxed warningApprovedCheplapharmSmall moleculeAntagonist58
        PramipexoleApprovedBoehringer Ingelheim PharmaceuticalsSmall moleculeAgonistD2-like dopamine receptor agonist14
        HaloperidolBoxed warningApprovedBosnalijek D.DSmall moleculeInverse agonistD2-like dopamine receptor inverse agonist12
        Haloperidol decanoateBoxed warningApprovedJohnson & JohnsonSmall moleculeInverse agonistD2-like dopamine receptor inverse agonist12
        ApomorphineApprovedMDD USSmall moleculeAgonistD2-like dopamine receptor agonist11
        BromocriptineApprovedEsjay PharmaSmall moleculeAgonistD2-like dopamine receptor agonist5
        DroperidolWithdrawn Boxed warningApprovedRising PharmaceuticalsSmall moleculeAntagonist5
        RotigotineApprovedUCBSmall moleculeAgonistD2-like dopamine receptor agonist5
        ChlorpromazineBoxed warningApprovedAstraZeneca PharmaceuticalsSmall moleculeAntagonist4
        RopiniroleBoxed warningApprovedGSKSmall moleculeAgonistD2-like dopamine receptor agonist2
        TrifluoperazineBoxed warningApprovedGSKSmall moleculeAntagonist1
        LevomepromazineApprovedAmgenSmall moleculeAntagonist0
        LoxapineBoxed warningApproved—Small moleculeAntagonist0
        PromazineApprovedPfizerSmall moleculeAntagonist0
        ThioridazineWithdrawn Boxed warningApproved—Small moleculeAntagonist0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 53 in all, from ClinicalTrials.gov.
        Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult ParticipantsOlanzapinePhase 1Not yet recruitingNeurelis, Inc.Nov 6, 2026
        Netupitant/Palonosetron for Prevention of Nausea and Vomiting in Breast Cancer ADC TherapyOlanzapinePhase 2Not yet recruitingFudan UniversityNov 5, 2026
        Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast CancerOlanzapinePhase 2Not yet recruitingWashington University School of MedicineNov 3, 2026
        Real-World Impact of TV-44749 in Adults With SchizophreniaOlanzapine—Not yet recruitingTeva Branded Pharmaceutical Products R&D LLCNov 3, 2026
        Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective DisorderHaloperidol decanoate, Haloperidol—RecruitingBosnalijek D.DOct 5, 2026
        Safety, Tolerability, and Pharmacokinetics of DM1001 Transdermal Patch in Healthy Chinese ParticipantsPramipexolePhase 1Not yet recruitingThe Third Xiangya Hospital of Central South UniversitySep 28, 2026
        Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid TumorsOlanzapinePhase 2Active, not recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologySep 25, 2026
        Acupuncture to Prevent Nausea and Vomiting After Stem Cell TransplantOlanzapineNot applicableEnrolling by invitationXiao WangAug 5, 2026
        Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk FactorsOlanzapineNot applicableRecruitingAlexandria UniversityAug 4, 2026
        Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency DepartmentHaloperidol decanoate, HaloperidolEarly phase 1Not yet recruitingUniversity of Illinois ChicagoJul 24, 2026
        A Nutrition and Exercise Program With Olanzapine Compared to Olanzapine Alone: A Trial in Patients With Advanced TumorsOlanzapinePhase 2Not yet recruitingKantonsspital Winterthur KSWJul 23, 2026
        The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy IndividualsApomorphineNot applicableEnrolling by invitationUniversity of CopenhagenJul 7, 2026
        Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic DepressionPramipexolePhase 3RecruitingDaniel LindqvistJun 24, 2026
        TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk PatientsDroperidolNot applicableRecruitingZhejiang UniversityMar 18, 2026
        SAD Study in Patients With Parkinson's Disease and Motor FluctuationsApomorphinePhase 1RecruitingSerina TherapeuticsFeb 20, 2026
        Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's DiseaseApomorphine—RecruitingDanish Research Centre for Magnetic ResonanceFeb 11, 2026
        Pramipexole and the Risk of Serious Adverse EventsPramipexole—Active, not recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sFeb 3, 2026
        Safety and Preliminary Efficacy of Hibernation-Like Therapy (Chlorpromazine and Promethazine) in Patients With Acute Ischemic Stroke (AIS) Eligible for Reperfusion Therapy.ChlorpromazineNot applicableNot yet recruitingJi Xunming,MD,PhDJan 23, 2026
        Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of LifeApomorphine—RecruitingCentre Hospitalier Régional d'OrléansDec 2, 2025
        Single-dose,First-in-human of KLA478PramipexolePhase 1RecruitingHunan Kelun Pharmaceutical Co., Ltd.Nov 21, 2025
        Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:Apomorphine—RecruitingSupernus Pharmaceuticals, Inc.Oct 22, 2025
        SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world TreatmentApomorphine—RecruitingBial - Portela C S.A.Aug 28, 2025
        A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate TabletsBromocriptinePhase 3RecruitingChangchun GeneScience Pharmaceutical Co., Ltd.Aug 15, 2025
        Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?Haloperidol decanoate, HaloperidolPhase 4RecruitingCentre for Addiction and Mental HealthAug 7, 2025
        Stratified Pharmacological Approaches for Regulating Circuit-Level EffectsPramipexolePhase 2RecruitingStanford UniversityJun 15, 2025
        Assessment of Drug Liking In Peri-procedural Clinical SettingsDroperidolEarly phase 1Enrolling by invitationStanford UniversityJun 11, 2025
        Adhesion and Safety of Rotigexole Compared to Neupro®RotigotineNot applicableNot yet recruitingEva PharmaJun 11, 2025
        Effect of Amitriptyline and Trifluoperazine on Patients With Functional DyspepsiaTrifluoperazinePhase 2 / Phase 3RecruitingMd. Moktadirul Hoque ShuvoJun 6, 2025
        Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain InjuryHaloperidol decanoate, HaloperidolNot applicableNot yet recruitingBenha UniversityMay 28, 2025
        Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip ArthroplastyDroperidolNot applicableRecruitingInstitut Mutualiste MontsourisMay 21, 2025
        Droperidol and QTc Interval Changes in ED PatientsDroperidol—RecruitingCHRISTUS HealthDec 10, 2024
        A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's DiseaseRotigotinePhase 3RecruitingI.R.C.C.S. Fondazione Santa LuciaNov 22, 2024
        Study on Hibernation-like Therapy Based on Mechanical ThrombectomyChlorpromazinePhase 1RecruitingCapital Medical UniversityOct 29, 2024
        Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)PramipexolePhase 2RecruitingClinical Academic Center (2CA-Braga)Sep 25, 2024
        Precision Care for Major Depressive DisorderPramipexolePhase 4Enrolling by invitationUniversity of California, San FranciscoAug 30, 2024
        Surgical and Pharmacological Efficacy of Knosp Grade 0-2 ProlactinomaBromocriptineNot applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineAug 15, 2024
        A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPDPramipexolePhase 2Active, not recruitingAreteia TherapeuticsAug 1, 2024
        Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency DepartmentHaloperidol decanoate, HaloperidolPhase 4RecruitingWestern Michigan University School of MedicineMay 2, 2024
        Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney DiseaseRotigotinePhase 2RecruitingUniversity Hospital, RouenMar 4, 2024
        Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive AgeBromocriptinePhase 3RecruitingJimma UniversityFeb 9, 2024
        The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBMHaloperidol decanoate, HaloperidolPhase 2Not yet recruitingSouthern Medical University, ChinaJan 23, 2024
        Maternal And Infant Antipsychotic StudyHaloperidol decanoate, Haloperidol—RecruitingIcahn School of Medicine at Mount SinaiSep 22, 2023
        The Danish Out-of-Hospital Cardiac Arrest StudyHaloperidol decanoate, HaloperidolPhase 3Active, not recruitingChristian HassagerJun 9, 2023
        Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing StrategyChlorpromazinePhase 2 / Phase 3Active, not recruitingM.D. Anderson Cancer CenterJun 24, 2022
        Apomorphine in Severe Brain-injured PatientsApomorphinePhase 2 / Phase 3RecruitingUniversity of LiegeJan 28, 2022
        Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyBromocriptinePhase 4RecruitingDennis M. McNamara, MD, MSJan 6, 2022
        Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)Apomorphine—Not yet recruitingUniversity Hospital, Strasbourg, FranceOct 8, 2021
        Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm RepairDroperidolPhase 4RecruitingUniversity of CreteMay 20, 2021
        Bromocriptine for Patients With Schizophrenia and PrediabetesBromocriptinePhase 4Not yet recruitingVA Pittsburgh Healthcare SystemJul 2, 2018
        Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent CancerChlorpromazinePhase 2 / Phase 3Active, not recruitingM.D. Anderson Cancer CenterJan 16, 2017
        Gait Analysis in Neurological DiseaseRopinirole—Active, not recruitingBeth Israel Deaconess Medical CenterDec 16, 2016
        Quality Improvement and Practice Based Research in Neurology Using the EMRRotigotinePhase 4Enrolling by invitationEndeavor HealthFeb 1, 2016
        Infusion of Apomorphine: Long-term Safety StudyRopinirole, RotigotinePhase 3Active, not recruitingMDD US Operations, LLC a subsidiary of Supernus PharmaceuticalsJan 15, 2015

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2331075, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.